273 related articles for article (PubMed ID: 34276914)
1. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.
Semeraro N; Colucci M
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021045. PubMed ID: 34276914
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy of Acute Sepsis.
Semeraro N; Ammollo CT; Semeraro F; Colucci M
Semin Thromb Hemost; 2015 Sep; 41(6):650-8. PubMed ID: 26305237
[TBL] [Abstract][Full Text] [Related]
3. Sepsis, thrombosis and organ dysfunction.
Semeraro N; Ammollo CT; Semeraro F; Colucci M
Thromb Res; 2012 Mar; 129(3):290-5. PubMed ID: 22061311
[TBL] [Abstract][Full Text] [Related]
4. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
Gando S; Wada T
Front Immunol; 2021; 12():649122. PubMed ID: 34177896
[TBL] [Abstract][Full Text] [Related]
5. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
6. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects.
Mizurini DM; Hottz ED; Bozza PT; Monteiro RQ
Front Cardiovasc Med; 2021; 8():785738. PubMed ID: 34977191
[TBL] [Abstract][Full Text] [Related]
7. The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19.
Bahraini M; Dorgalaleh A
Semin Thromb Hemost; 2022 Feb; 48(1):19-30. PubMed ID: 34695858
[TBL] [Abstract][Full Text] [Related]
8. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.
Semeraro N; Ammollo CT; Semeraro F; Colucci M
Mediterr J Hematol Infect Dis; 2010 Aug; 2(3):e2010024. PubMed ID: 21415977
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of coronavirus-19 disease.
Borczuk AC; Yantiss RK
J Biomed Sci; 2022 Oct; 29(1):87. PubMed ID: 36289507
[TBL] [Abstract][Full Text] [Related]
10. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
11. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
13. [SARS-CoV-2 infection as a thrombo-inflammatory endothelial disease].
Samaniego F; Conte G
Rev Med Chil; 2020 Oct; 148(10):1467-1474. PubMed ID: 33844717
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management.
Ortega-Paz L; Capodanno D; Montalescot G; Angiolillo DJ
J Am Heart Assoc; 2021 Feb; 10(3):e019650. PubMed ID: 33228447
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
18. Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.
García-Ortega A; de la Rosa D; Oscullo G; Castillo-Villegas D; López-Reyes R; Martínez-García MÁ
J Thorac Dis; 2021 Feb; 13(2):1239-1255. PubMed ID: 33717596
[TBL] [Abstract][Full Text] [Related]
19. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19.
D'Agnillo F; Walters KA; Xiao Y; Sheng ZM; Scherler K; Park J; Gygli S; Rosas LA; Sadtler K; Kalish H; Blatti CA; Zhu R; Gatzke L; Bushell C; Memoli MJ; O'Day SJ; Fischer TD; Hammond TC; Lee RC; Cash JC; Powers ME; O'Keefe GE; Butnor KJ; Rapkiewicz AV; Travis WD; Layne SP; Kash JC; Taubenberger JK
Sci Transl Med; 2021 Nov; 13(620):eabj7790. PubMed ID: 34648357
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.
Stenmark KR; Frid MG; Gerasimovskaya E; Zhang H; McCarthy MK; Thurman JM; Morrison TE
Pulm Circ; 2021; 11(2):20458940211015799. PubMed ID: 34046161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
